核糖核酸
中枢神经系统
神经科学
细胞内
翻译(生物学)
RNA干扰
限制
小RNA
药物输送
计算生物学
化学
信使核糖核酸
细胞生物学
纳米医学
治疗方法
生物
小干扰RNA
医学
输送系统
生物信息学
纳米技术
神经系统
间充质干细胞
作者
Maggie Magaw,Eshan A. Narasipura,Rachel VanKeulen‐Miller,Owen S. Fenton
标识
DOI:10.1021/acs.molpharmaceut.6c01318
摘要
Abstract Lipid nanoparticles (LNPs) have emerged as an adaptable platform for the delivery of therapeutic RNA, as demonstrated by the clinical success of mRNA vaccines and RNA interference therapies. Despite this progress, translation of RNA LNPs to diseases of the central nervous system (CNS) remains challenging due to multiple biological barriers that restrict access to neural tissue and target cells. Beyond crossing the blood-brain barrier and related CNS interfaces, further obstacles include efficient tissue distribution, cell-specific uptake, and intracellular RNA delivery. This review summarizes CNS-relevant delivery routes, key anatomical and cellular barriers limiting therapeutic access to neural tissues, major therapeutic RNA modalities, and the chemical composition and design principles of LNPs. We further discuss engineering strategies developed to overcome these obstacles and highlight emerging therapeutic applications across neuro-oncology, acute CNS injury, and neurodegenerative disorders. Collectively, RNA LNPs demonstrate potential as a versatile carrier system for neurological disease. However, further advances in delivery strategies will likely be needed to improve brain access, distribution, cell-specific targeting, and intracellular RNA delivery across diverse CNS applications.
科研通智能强力驱动
Strongly Powered by AbleSci AI